학술논문

Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial
Document Type
Article
Source
In: The Lancet Diabetes and Endocrinology. (The Lancet Diabetes and Endocrinology, 1 July 2019, 7(7):528-539)
Subject
Language
English
ISSN
22138595
22138587